Cargando…

Status of Using Complementary and Alternative Medicine among Patients with Cancer in Korea: an Online Survey of Online Cancer Support Groups (KCSG PC21-20)

PURPOSE: An increasing number of patients with cancers are interested in complementary and alternative medicine (CAM), which lacks scientific evidence. This study aimed to determine how CAM was used and how media affected patients in online cancer support groups (OCSG). MATERIALS AND METHODS: Betwee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Sun, Kwon, Jung Hye, Rha, Sun Young, Lee, Sang-Cheol, Chang, Yoon Jung, Kwon, In-Sun, You, Kyung Han, Yoon, Ho Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101804/ https://www.ncbi.nlm.nih.gov/pubmed/36596728 http://dx.doi.org/10.4143/crt.2022.1483

Ejemplares similares

Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients
por: Kwon, Jung Hye, et al.
Publicado: (2019)

Treatment pattern of chronic lymphocytic leukemia/small lymphocytic lymphoma in Korea: a multicenter retrospective study (KCSG LY20-06)
por: Kim, Jung Sun, et al.
Publicado: (2023)

Understanding the Social Mechanism of Cancer Misinformation Spread on YouTube and Lessons Learned: Infodemiological Study
por: Yoon, Ho Young, et al.
Publicado: (2022)

Correction: Understanding the Social Mechanism of Cancer Misinformation Spread on YouTube and Lessons Learned: Infodemiological Study
por: Yoon, Ho Young, et al.
Publicado: (2022)

Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study
por: Hwang, In Gyu, et al.
Publicado: (2021)

Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
por: Lee, Jieun, et al.
Publicado: (2023)

Trends and an Online Survey on the Use of Rigid Bronchoscopy in Korea
por: Jeong, Byeong-Ho, et al.
Publicado: (2022)

Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study
por: Kim, Jin Won, et al.
Publicado: (2018)

Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG‐RC20‐06
por: Sohn, Byeong Seok, et al.
Publicado: (2023)

Quality Assessment of Online Complementary and Alternative Medicine Information Resources Relevant to Cancer
por: Sansevere, Megan E., et al.
Publicado: (2021)

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)
por: Han, Hye Sook, et al.
Publicado: (2021)

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
por: Jung, Minkyu, et al.
Publicado: (2012)

Current utilization and influencing factors of complementary and alternative medicine among children with neuropsychiatric disease: a cross-sectional survey in Korea
por: Jeong, Min-Jeong, et al.
Publicado: (2016)

Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)
por: Kang, Eun Joo, et al.
Publicado: (2022)

Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study
por: Hwang, Jung Hye, et al.
Publicado: (2020)

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
por: Lee, Ki Hyeong, et al.
Publicado: (2015)

AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)
por: Suh, Koung Jin, et al.
Publicado: (2023)

The use of complementary and alternative medicine (CAM) in children: a telephone-based survey in Korea
por: Kim, Jung-Ha, et al.
Publicado: (2012)

Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22
por: Jung, Hyun Ae, et al.
Publicado: (2022)

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07
por: Kim, Miso, et al.
Publicado: (2020)

Burden of Cancer Due to Cigarette Smoking and Alcohol Consumption in Korea
por: Jung, Yoon-Sun, et al.
Publicado: (2022)

Monitoring in clinical trials of complementary and alternative medicine
por: Jung, So-Young, et al.
Publicado: (2021)

The Use of Complementary and Alternative Medicine in a General Population in South Korea: Results from a National Survey in 2006
por: Ock, Sun Myeong, et al.
Publicado: (2009)

The Anticancer Effect of Fucoidan in PC-3 Prostate Cancer Cells
por: Boo, Hye-Jin, et al.
Publicado: (2013)

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
por: Choi, Yoon Ji, et al.
Publicado: (2018)

Changes in spatial clusters of cancer incidence and mortality over 15 years in South Korea: Implication to cancer control
por: Nguyen, Cham Thi, et al.
Publicado: (2023)

Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)
por: Sun, Jong-Mu, et al.
Publicado: (2018)

Online Mental Health Assessments of COVID-19 Patients in South Korea
por: Lee, Jung Hyun, et al.
Publicado: (2021)

Evaluation of the quality of online patient information at the intersection of complementary and alternative medicine and hypertension
por: Ng, Jeremy Y., et al.
Publicado: (2022)

Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
por: Lee, Si Won, et al.
Publicado: (2023)

Awareness and Use of Complementary and Alternative Medicine in Korean Lung Cancer Patients
por: Choi, Joon Young, et al.
Publicado: (2021)

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
por: Kim, Seung Tae, et al.
Publicado: (2022)

A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03)
por: Lee, Dae-Won, et al.
Publicado: (2023)

The utilisation of Complementary and Alternative Medicine (CAM) among ethnic minorities in South Korea
por: Hwang, Jung Hye, et al.
Publicado: (2014)

The NA48 online and offline PC farms
por: Peters, A
Publicado: (2000)

Use of Complementary and Alternative Medicine (CAM) in Patients With Colorectal Cancer
por: Yeom, Jeongwon, et al.
Publicado: (2022)

Complementary and Alternative Medicine for Long COVID: Scoping Review and Bibliometric Analysis
por: Kim, Tae-Hun, et al.
Publicado: (2022)

Trends and Patterns of Cancer Burdens by Region and Income Level in Korea: A National Representative Big Data Analysis
por: Jung, Yoon-Sun, et al.
Publicado: (2023)

Predictors of Complementary and Alternative Medicine Use in Cancer Care: Results of a Nationwide Multicenter Survey in Korea
por: Shin, Ji-Yeon, et al.
Publicado: (2012)

Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
por: Lee, Eun-Gyeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kn12p0jcp4p6iltt0tvt7tgg27